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Surgical Approach of Synchronous Medullary Thyroid Carcinoma 
and Pheochromocytoma in MEN 2 Syndrome 
Georg F. W. Scheumann,* and Henning Dralle' 
In cases with concurrent medullary thyroid carcinoma (MTC) and pheochromocytoma, discussion 
regarding a one-stage versus two-stage treatment strategy approach remains open. From 1975 to 
1990, 11 of 25 multiple endocrine neoplasia type 2 (MEN 2) patients presented with biendo-
crinopathies or triendocrinopathies synchronously. All patients were treated surgically and followed 
subsequently in our hospital. Of the group of nine patients with concurrent MTC and pheochromo-
cytoma, five were treated in one-stage and four in two-stage procedures. No patient had major 
complications intraoperatively. For the two-stage group, the total hospital stay (preoperatively and 
postoperatively) averaged35 days. For the one-stage group, the total hospital .stay averaged 25 days. 
In patients with increased operative risks (patients with higher age and impaired physical condition 
or if neck surgery includes transstemal cervicomediastinal lymphadenectomy), two-stage procedures 
should be selected. However, in young patients with the MEN 2 syndrome or syndromes with .small 
tumors detected by family screening, thyroidectomy, cervical lymphadenectomy, and adrenalectomy 
may be performed in a one-stage procedure without increasing surgically related morbidity. (Henry 
Ford Hosp Med J 1992;40:278-80) 
The multiple endocrine neoplasia type 2 (MEN 2) syndrome appears in two variants. MEN 2A is defined as the MEN 2 
syndrome without the mucosal neuroma phenotype, and MEN 
2B as the MEN 2 syndrome with the mucosal neuroma pheno-
type (1). The majority of hereditary cases belong to the MEN 2A 
(70%) or famdial non-MEN 2 A variant (17% to 24%); only 6% 
to 13% are of the mucosal neuroma phenotype (MEN 2B) (2-4). 
The syndrome is a genetically transmitted disease which pre-
dominantly affects the thyroid, parathyroid, and adrenal glands. 
Although surgery is generally regarded as the treatment of 
choice for each stage ofthe disease, the extent of surgical resec-
tion ofthe involved endocrine organs and the surgical time strat-
egy in cases of synchronously involved glands is still debatable. 
In cases with concurrent medullary thyroid carcinoma (MTC) 
and hyperparathyroidism (HPT), the procedure with total thy-
roidectomy and parathyroidectomy performed in a one-stage 
operation is generally accepted because the extent of resection 
and operative risk for the patient does not differ from that for 
one-gland disease (2,5). 
However, in cases with concurrent MTC and pheochromocy-
toma, discussion regarding treatment strategy (one-stage versus 
two-stage approach) remains open. We present our surgical ap-
proach in MEN 2 patients with regard to the synchronous ap-
pearance of MTC and pheocfiromocytoma. 
patients were treated surgically and were followed subsequently 
at our hospital. The patients" data were stored, maintained, and 
evaluated by the Clinical Cancer Registry of the Medical School 
of Hannover. The information system used was developed and 
established under the DSM-11 (Digital Standard MUMPS) data 
base management and operating system. ("MUMPS" is the ac-
ronym for the Massachusetts General Hospital Utility Multi-
programming System which was originally developed at the 
Laboratory of Computer Science at Massachusetts General 
Hospital.) 
Results 
In the 11 patients (44% of all MEN 2 patients) with synchro-
nous biendocrinopathies or triendocrinopathies, two patients 
suffered from synchronous MTC and HPT (patients 202 and 
304). Another two patients showed MTC, HPT. and pheochro-
mocytoma (patients 101 and 503) at the time of clinical presen-
tation. In seven patients, MTC and pheochromocytoma were 
demonstrated concurrendy (Table). Four had bilateral pheo-
chromocytoma. Bilateral pheochromocytoma occurred more 
frequentiy in patients with synchronous pheochromocytoma 
Patients and Methods 
From 1975 to 1990, 11 of 25 MEN 2 patients presented with 
biendocrinopathies or triendocrinopathies synchronously. Al l 
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Table 
Surgical Procedure in Nine Patients With Synchronous MEN 2/MTC and Pheochromocytoma (1975-1990) 
Number One-Stage 
Day of 
Discharge Complications Number Two-Stage 
Day of 
Di.scharge Complications 
102 TT, parathyroidectomy, 
transperitoneal 
bilateral total 
adrenalectomy 
302 TT, parathyroidectomy, 
transperitoneal left 
total and right sub-
total adrenalectomy 
305 TT, parathyroidectomy, 
transperitoneal left 
and right subtotal 
adrenalectomy 
601 TT, transperitoneal 
left total 
adrenalectomy 
1101 TT, transperitoneal 
left total 
adrenalectomy 
17 
1^ ) 
24 
13 
101 
502 
503 
504 
December 1990, 
right translumbar 
total adrenalectomy 
March 1991, TT 
December 1986, TT 
July 1987, trans-
lumbar right total 
adrenalectomy 
March 1987, TT 
May 1988, trans-
peritoneal bilateral 
total adrenalectomy 
with adrenocortical 
autotransplantation 
left forearm 
December 1987, 
transperitoneal 
right total 
adrenalectomy 
April 1988, TT 
4 
2 
7 
8 
15 
22 
Intermittent 
bradyarrhythmia 
Pneumonia 
TT = total thyroidectomy. 
and MTC, as opposed to those with metachronal pheochro-
mocytoma and MTC (6). 
Ofthe group of nine patients with concurrent MTC and pheo-
chromocytoma, five were treated in a one-stage and four in a 
two-stage procedure. No patient had major complications in-
traoperatively. Preoperatively, all patients with synchronous 
MTC and pheochromocytoma were treated with a high dosage 
of a-receptor blockage (mean 270 mg phenoxybenzamine) for 
13 to 25 days. 
Two-stage group 
The three females and two males had a mean age of 67 years 
(range 48 to 69 years). Two patients underwent thyroidectomy 
first because of symptomatic MTC (patients 502 and 503). They 
had been treated preoperatively with high dosage of a-receptor 
blockage without any intraoperative or postoperative complica-
tions. The two other patients were treated first by adrenalectomy 
and then by thyroidectomy. One patient had pneumonia after the 
primary transperitoneal unilateral adrenalectomy (patient 504) 
and was discharged from hospital on the 22nd postoperative 
day. Another patient experienced a short period of intermittent 
bradyarrhythmia immediately after unilateral translumbar adre-
nalectomy but without any delay in his hospital stay. The dura-
tion of postoperative care averaged 12 days forthe single opera-
tive procedure and a total of 17.5 days for the two operative pro-
cedures for a total hospital stay (pre- and postoperative) averag-
ing 35 days (Figure). 
Two stage OP I I One stage OP 
Figure—Comparison of patients' ages and length of hospital 
stays for one- and two-stage procedures. 
One-stage group 
The tfiree females and one male had a mean age of 29.4 years 
(range 15 to 54 years). The surgical procedure in one-stage oper-
ations was cervical surgery followed by abdominal or lateral ap-
proach to the adrenal gland. There were no postoperative com-
plications. The mean postoperative stay was 16.4 days with a to-
tal hospital stay (preoperatively and postoperatively) averaging 
25 days (Figure). 
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Discussion 
Surgical management of MEN 2 patients includes preopera-
tive diagnostic procedures identifying the organs involved (7,8), 
preoperative medical treatment of patients with pheochromocy-
toma before adrenalectomy (9), and perioperative a-receptor 
blockade at the time of cervical intervention in patients with a 
pheochromocytoma diathesis not yet considered for adrenalec-
tomy (6). Surgical strategy includes the management of patients 
with synchronous or metachronous multiorgan manifestations 
and the surgical technique of thyroid, parathyroid, and adrenal 
gland resection. 
Of our MEN 2 patients, 44% presented with synchronous bi-
endocrinopathies or triendocrinopathies. This group is hetero-
geneous, with an age range from 15 to 69 years, an MTC tumor 
stage variation from T l to T4, and pheochromocytoma with or 
without clinical symptoms and unilateral or bilateral disease. 
Therefore, a general strategy for surgical procedure could not be 
given. The decision between one-stage or two-stage procedure 
with adrenalectomy first as routine procedure, or thyroidectomy 
first in the case of dominating malignant cervical disease, must 
be made individually based on the patient's physical and MEN 
2-related condition if appropriate a-receptor blocking pretreat-
ment is followed (9-11). In patients with increased operative 
risks (i.e., higher age, impaired physical condition, or if neck 
surgery includes transstemal cervicomediastinal lymphadenec-
tomy), two-stage procedures should be selected. However, in 
young patients with the MEN 2 syndrome (12) and syndromes 
such as pheochromocytoma and small MTC detected by family 
screening, thyroidectomy, cervical lymphadenectomy, and adre-
nalectomy may be pertbrmed in a one-stage procedure with di-
minished individual discomfort attended with a second surgi-
cal intervention and without increased surgically related mor-
bidity. 
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